Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 18, 2008 12:43 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Enters Major Contract With Lovelace Respiratory Institute

PHILADELPHIA, Nov. 18, 2008 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) announced it has entered a contract, valued at more than $1 Million, with Lovelace Respiratory Research Institute...
November 10, 2008 14:35 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma, Inc. Releases Financial Results for the Three Months Ended September 30, 2008

PHILADELPHIA, Nov. 10, 2008 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) announced its financial results for the fiscal quarter ended September 30, 2008. The net loss including non-cash...
October 28, 2008 09:00 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Selected to Present At 7th Annual BIO Investor Forum

PHILADELPHIA, Oct. 28, 2008 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) announced its selection as a presenting company at the Biotechnology Industry Organization (BIO) Seventh Annual...
October 27, 2008 09:30 ET | Source: Hemispherx Biopharma, Inc.

Immune Adjuvants and Cancer Vaccines: Hemispherx's New Enhancement Strategy

PHILADELPHIA, Oct. 27, 2008 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) said that its collaborator, Advanced Immune Therapeutics ("AIT") (Wellesley, MA), will present new data on...
October 23, 2008 09:00 ET | Source: Hemispherx Biopharma, Inc.

Nobel Laureate Confirms Importance of Adjuvants in Controlling Devastating Diseases

PHILADELPHIA, Oct. 23, 2008 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) noted today that a member of its Scientific Advisory Board, Prof. Luc Montagnier, a winner of the 2008 Nobel Prize...
October 21, 2008 09:00 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma to Present At 48th Annual ICAAC Conference

PHILADELPHIA, Oct. 21, 2008 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) today announced that its Medical Director, Dr. David Strayer, will present clinical data at the 48th Annual...
October 17, 2008 16:00 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma, Inc. Adjourns Stockholder Meeting to November 11, 2008

PHILADELPHIA, Oct. 17, 2008 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) today announced that it adjourned its annual stockholders' meeting to Tuesday, November 11, 2008 at 10:00 a.m. at...
October 09, 2008 09:00 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Scientific Advisory Board Member, Dr. Luc Montagnier, Receives Nobel Prize for Medicine

PHILADELPHIA, Oct. 9, 2008 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) today congratulated Dr. Luc Montagnier on the award of the 2008 Nobel Prize for Medicine for the discovery of the...
October 06, 2008 14:29 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Engages The Sage Group as Its Corporate Partnership Advisor for Ampligen to Treat Chronic Fatigue Syndrome

PHILADELPHIA, Oct. 6, 2008 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (Amex:HEB) today announced that it has engaged The Sage Group to assist Hemispherx to identify, select, negotiate, and close a...
September 30, 2008 09:30 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx to Present Data At 'Second World Conference On Magic Bullets (Erlich II)'

PHILADELPHIA, Sept. 30, 2008 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) announced that a member of its Board of Directors, Professor William M. Mitchell, M.D., Ph.D., will deliver an...